4.7 Editorial Material

Pearls & Oy-sters: Pembrolizumab-induced myasthenia gravis

Journal

NEUROLOGY
Volume 91, Issue 14, Pages E1365-E1367

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0000000000006278

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial

James F. Howard, Richard J. Nowak, Gil Wolfe, Miriam L. Freimer, Tuan H. Vu, John L. Hinton, Michael Benatar, Petra W. Duda, James E. MacDougall, Ramin Farzaneh-Far, Henry J. Kaminski

JAMA NEUROLOGY (2020)

Article Clinical Neurology

Correlation of Quantitative Myasthenia Gravis and Myasthenia Gravis Activities of Daily Living scales in the MGTX study

Tarrant McPherson, Inmaculada Aban, Petra W. Duda, Ramin Farzaneh-Far, Gil Wolfe, Henry J. Kaminski, Gary Cutter, Ikjae Lee

MUSCLE & NERVE (2020)

Review Immunology

Complement Inhibitor Therapy for Myasthenia Gravis

Khaled Albazli, Henry J. Kaminski, Jr James F. Howard

FRONTIERS IN IMMUNOLOGY (2020)

Review Oncology

Monoclonal Antibody-Based Therapies for Myasthenia Gravis

Sawsan Alabbad, Mohanad AlGaeed, Patricia Sikorski, Henry J. Kaminski

BIODRUGS (2020)

Article Health Care Sciences & Services

Gender differences in quality of life among patients with myasthenia gravis in China

Dong Dong, Marc Ka-chun Chong, Yushan Wu, Henry Kaminski, Gary Cutter, Xianhao Xu, Haifeng Li, Chongbo Zhao, Jian Yin, Siyue Yu, Jianfeng Zhu

HEALTH AND QUALITY OF LIFE OUTCOMES (2020)

Article Immunology

The Presence of Survivin on B Cells from Myasthenia Gravis Patients and the Potential of an Antibody to a Modified Survivin Peptide to Alleviate Weakness in an Animal Model

Xiangyang Zhang, Michael Ciesielski, Robert A. Fenstermaker, Henry J. Kaminski, Linda L. Kusner

JOURNAL OF IMMUNOLOGY (2020)

Article Psychology, Clinical

Sex differences in reporting of concussion symptoms in adults

Stephen C. Bunt, Nyaz Didehbani, Christian LoBue, Mathew Stokes, Morgan Heinzelmann, Heidi Rossetti, Shane M. Miller, Paul A. Nakonezny, Kathleen Bell, Hunt Batjer, C. Munro Cullum

Summary: This study examines differences in concussion symptom reporting between adult females and males, finding that females report higher levels of symptom severity and an increased risk of developing these symptoms following a concussion.

CLINICAL NEUROPSYCHOLOGIST (2022)

Letter Clinical Neurology

COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)

Srikanth Muppidi, Jeffrey T. Guptill, Saiju Jacob, Yingkai Li, Maria E. Farrugia, Amanda C. Guidon, Jinny O. Tavee, Henry Kaminski, James F. Howard, Gary Cutter, Heinz Wiendi, Matthew B. Maas, Isabel Illa, Renato Mantegazza, Hiroyuki Murai, Kimiaki Utsugisawa, Richard J. Nowak

LANCET NEUROLOGY (2020)

Article Multidisciplinary Sciences

Thymus-derived B cell clones persist in the circulation after thymectomy in myasthenia gravis

Ruoyi Jiang, Kenneth B. Hoehn, Casey S. Lee, Minh C. Pham, Robert J. Homer, Frank C. Detterbeck, Inmaculada Aban, Leslie Jacobson, Angela Vincent, Richard J. Nowak, Henry J. Kaminski, Steven H. Kleinstein, Kevin C. O'Connor

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Review Clinical Neurology

Post-Traumatic Gliomas in Adults: Review of the Case Reports and Studies

Morgan Heinzelmann, Edward Pan

Summary: This article reviews the literature on the relationship between traumatic brain injury (TBI) and glioma formation in adults. Case reports describe glioma formation at the site of prior brain injury, while observational studies mostly show no association. However, one prospective study found a positive association. Overall, glioma formation after TBI is a rare occurrence that requires further study.

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2023)

Article Clinical Neurology

The best and worst of times in therapy development for myasthenia gravis

Michael Benatar, Gary Cutter, Henry J. Kaminski

Summary: The US FDA has approved drugs for the treatment of myasthenia gravis, but questions remain regarding which patients benefit the most and the relative effectiveness of these drugs.

MUSCLE & NERVE (2023)

Article Clinical Neurology

Posttraumatic Headache

Morgan Heinzelmann, Christine Woods, Bert B. Vargas, Mathew Stokes

Summary: Posttraumatic headache (PTH) is a common secondary headache disorder following concussion, but the underlying mechanisms and specific treatment for PTH are still poorly understood. Further research is needed to define and validate the diagnosis of PTH, understand its pathophysiology, and find more effective treatments.

SEMINARS IN NEUROLOGY (2022)

Article Clinical Neurology

Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO

Antoine Regnault, Thomas Morel, Christine de la Loge, Flora Mazerolle, Henry J. Kaminski, Ali A. Habib

Summary: Myasthenia gravis (MG) is a chronic disease that affects the communication between nerves and muscles. The severity of MG can be assessed based on symptoms, with more symptoms indicating more severe disease. Muscle weakness in the eyes may represent a unique aspect of MG and requires further investigation.

NEUROLOGY AND THERAPY (2023)

Article Multidisciplinary Sciences

Serum metabolomics of treatment response in myasthenia gravis

Patricia Sikorski, Yaoxiang Li, Mehar Cheema, Gil I. Wolfe, Linda L. Kusner, Inmaculada Aban, Henry J. Kaminski

Summary: The study identified that high levels of phospholipids in serum were associated with treatment response in MG patients. It also found a panel of markers including histidine, free fatty acid, gamma-cholestenol, and guanosine that were highly predictive of treatment response. Pathway analysis suggested that xenobiotic metabolism may play a major role in treatment resistance, and individual variation in prednisone metabolism could impact treatment efficacy.

PLOS ONE (2023)

Correction Clinical Neurology

Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO (May 2023, 10.1007/s40120-023-00464-x)

Antoine Regnault, Thomas Morel, Christine de la Loge, Flora Mazerolle, Henry J. Kaminski, Ali A. Habib

NEUROLOGY AND THERAPY (2023)

No Data Available